CLINICAL_TRIALS
trial_result
· 2010-07-30
Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of GB-0998 for systemic sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Benesis Corporation | Conditions: Scleroderma, Systemic | Phase 3 | Status: COMPLETED